661 Results
Guidelines and Advice
Status: Current
ID: GL 2-21
Version: 2
ID: GL 2-21
Version: 2
Mar 2024
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
ID: GL-C50-24
Version: 3
Jan 2024
Guidelines and Advice
Mar 2025
Drug
Other Name(s): Herceptin®
, Kanjinti™; Ogivri™; Trazimera™; Herzuma®; Ontruzant®
Dec 2024
Drug
Aug 2025
Drug
Other Name(s): Suprefact®
, Suprefact Depot®
, Suprefact Nasal Spray®
Nov 2024
Drug
Sep 2025
Drug
Jan 2025
Drug
May 2024
Drug
Dec 2024
Drug
Aug 2025
Drug
Aug 2025